Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Schlessinger

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Archives of Dermatology|December 21, 2006
An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitisJoel Schlessinger, Bruce Miller, Richard D Gilbert, et al.
Aesthetic Surgery Journal|December 1, 2009
An analysis of the long-term safety data of repeat administrations of botulinum neurotoxin type A-ABO for the treatment of glabellar linesJoel L Cohen, Joel Schlessinger, Sue Ellen Cox, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 13, 2011
Time to onset of response of abobotulinumtoxina in the treatment of glabellar lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type AJoel Schlessinger, Gary Monheit, Michael A C Kane, et al.
Journal of Drugs in Dermatology : JDD|January 11, 2018
A Multicenter, Double-Blinded, Randomized, Split-Face Study of the Safety and Efficacy of a Novel Hyaluronic Acid Gel for the Correction of Nasolabial FoldsMichael H Gold, Leslie Stafford Baumann, Clifford P Clark, et al.
Journal of Drugs in Dermatology : JDD|January 8, 2016
A Firming Neck Cream Containing N-Acetyl Glucosamine Significantly Improves Signs of Aging on the Challenging Neck and DécolletageJoel Schlessinger, Barbara Green, Brenda L Edison, et al.
Journal of Drugs in Dermatology : JDD|January 10, 2022
Safety and Effectiveness of a Novel Hyaluronic Acid Gel for Lip AugmentationJeffery Adelglass, Javier Alonso-Llamazares, Jeremy Fenton, et al.
Journal of Drugs in Dermatology : JDD|June 23, 2009
The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatmentMark G Rubin, Jeffrey Dover, Richard G Glogau, et al.
Skinmed|April 2, 2013
Perceptions and practices in submental fat treatment: a survey of physicians and patientsJoel Schlessinger, Steven R Weiss, Mark Jewell, et al.
Journal of Drugs in Dermatology : JDD|January 26, 2019
Final Data from the Condition of Submental Fullness and Treatment Outcomes Registry (CONTOUR)Melanie D. Palm, Joel Schlessinger, Valerie D. Callender, et al.
Journal of Drugs in Dermatology : JDD|January 25, 2012
Short-term combination therapy and long-term relapse prevention in the treatment of severe acne vulgarisJerry Tan, Linda Stein Gold, Joel Schlessinger, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Archives of Dermatology|December 21, 2006
An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitisJoel Schlessinger, Bruce Miller, Richard D Gilbert, et al.
Aesthetic Surgery Journal|December 1, 2009
An analysis of the long-term safety data of repeat administrations of botulinum neurotoxin type A-ABO for the treatment of glabellar linesJoel L Cohen, Joel Schlessinger, Sue Ellen Cox, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 13, 2011
Time to onset of response of abobotulinumtoxina in the treatment of glabellar lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type AJoel Schlessinger, Gary Monheit, Michael A C Kane, et al.
Journal of Drugs in Dermatology : JDD|January 11, 2018
A Multicenter, Double-Blinded, Randomized, Split-Face Study of the Safety and Efficacy of a Novel Hyaluronic Acid Gel for the Correction of Nasolabial FoldsMichael H Gold, Leslie Stafford Baumann, Clifford P Clark, et al.
Journal of Drugs in Dermatology : JDD|January 8, 2016
A Firming Neck Cream Containing N-Acetyl Glucosamine Significantly Improves Signs of Aging on the Challenging Neck and DécolletageJoel Schlessinger, Barbara Green, Brenda L Edison, et al.
Journal of Drugs in Dermatology : JDD|January 10, 2022
Safety and Effectiveness of a Novel Hyaluronic Acid Gel for Lip AugmentationJeffery Adelglass, Javier Alonso-Llamazares, Jeremy Fenton, et al.
Journal of Drugs in Dermatology : JDD|June 23, 2009
The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatmentMark G Rubin, Jeffrey Dover, Richard G Glogau, et al.
Skinmed|April 2, 2013
Perceptions and practices in submental fat treatment: a survey of physicians and patientsJoel Schlessinger, Steven R Weiss, Mark Jewell, et al.
Journal of Drugs in Dermatology : JDD|January 26, 2019
Final Data from the Condition of Submental Fullness and Treatment Outcomes Registry (CONTOUR)Melanie D. Palm, Joel Schlessinger, Valerie D. Callender, et al.
Journal of Drugs in Dermatology : JDD|January 25, 2012
Short-term combination therapy and long-term relapse prevention in the treatment of severe acne vulgarisJerry Tan, Linda Stein Gold, Joel Schlessinger, et al.
Pageof 6